---
$id: https://graph.org.ai/products/commodity/51161536
$type: Product
source: UNSPSC
code: "51161536"
title: "Doxofylline"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Doxofylline

**UNSPSC Code**: 51161536
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor with the molecular formula C11H14N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MPM23GMO7Z, chemically known as 7-(1,3-dioxolon-2-ylmethyl)-1,2,3,6-tetrahydro-1,3-dimethyl-2,6-purindion but generally known as doxofylline, which bears US NIH Compound Identifier 50942. European Medicines Agency schedules Doxofylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06390MIG. The term DOXOFYLLINE is an International Non-Proprietary Name. World Health Organization schedules doxofylline in its Anatomical Therapeutic Chemical (ATC) Classification. DOXOFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule doxofylline under HS 29395900 and SITC 54145. As of Q4 2014, DOXOFYLLINE remains the US FDA Preferred Term for this commodity. Doxofylline bears US NLM identifiers UMLS ID C0058721 and NCI Concept Code C76317. SMILES: CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC3OCCO3.

